What are the typical symptoms of a sickle cell crisis and the recommended acute management?

Sickle Cell Crisis Symptoms and Acute Management

Sickle cell crisis presents with severe pain affecting the long bones, sternum, ribs, or back in older children and adults (dactylitis in infants), and requires immediate aggressive parenteral analgesia, hydration, and evaluation for life-threatening complications including acute chest syndrome, stroke, and infection. 1

Clinical Presentation of Acute Sickle Cell Crises

Pain Characteristics

• Acute painful crises are the hallmark manifestation, affecting fingers in infancy (dactylitis) and progressing to involve long bones, sternum, ribs, or back in older children and adults 1
• Pain intensity varies from mild to excruciating and is often more severe than other forms of pain such as postoperative pain 2
• Pain may be localized, involve multiple areas, be diffuse, or migratory in nature 2
• The crisis evolves through four phases: prodromal, initial, established, and resolving 3

Life-Threatening Complications Requiring Immediate Recognition

Acute Chest Syndrome (most critical to identify early):

• New onset respiratory symptoms including chest pain, fever, tachypnea, cough, and wheeze 1
• New pulmonary infiltrates on chest X-ray 1
• Common complication following surgery and a leading cause of mortality 1, 4
• Continuous SpO₂ monitoring is mandatory to provide early warning 5, 6

Neurological Complications:

• Stroke occurs in up to 10% of children with symptoms including hemiparesis, aphasia, dysphasia, seizures, monoparesis, severe headache, cranial nerve palsy, stupor, or coma 1
• Ischemic stroke or intracranial hemorrhage in adults 1
• Any acute neurologic symptom other than transient mild headache requires urgent evaluation 1

Acute Splenic Sequestration Crisis:

• Potentially life-threatening in children aged 5 months to 2 years 1
• Massive splenomegaly with acute anemia (Hb 10-30 g/L) and hypovolemic shock 1
• Rapid progression to shock and death if not recognized promptly 1

Aplastic Crisis:

• Commonly caused by parvovirus B19 infection (or Epstein-Barr virus or streptococcal infection) 1
• Characterized by exacerbation of baseline anemia with substantially decreased reticulocyte count (typically below 1%) 1
• Aplasia may last 5-10 days 1

Priapism:

• Prolonged painful erection occurring in two forms: stuttering episodes (<4 hours) or severe acute ischemic episodes (≥4 hours) 1
• May result in permanent impotence if prolonged beyond 4 hours 1

Immediate Acute Management Algorithm

Step 1: Rapid Triage and Pain Assessment

• Diagnose pain based solely on patient's self-report - there are rarely objective physical findings even with severe pain 5
• The patient's statement that they are in pain is the gold standard; initiate aggressive treatment immediately 5
• Use validated pain-assessment tools and compare to the patient's usual sickle cell pain episodes 5
• Critical pitfall to avoid: Delays in addressing and undertreatment of sickle cell pain are common errors 5

Step 2: Immediate Diagnostic Workup

Mandatory baseline tests:

• Complete blood count with reticulocyte count and compare to patient's known baseline to detect complications like sequestration or aplastic crisis 5, 7
• Oxygen saturation measurement and comparison to baseline 5
• Blood cultures if temperature ≥38.0°C or any signs of sepsis 1, 5, 7
• Chest X-ray if any respiratory symptoms, chest pain, or hypoxemia present to evaluate for acute chest syndrome 5

Step 3: Aggressive Pain Management

Patient-Controlled Analgesia (PCA) is the preferred method:

• PCA shows superior outcomes with lower overall morphine consumption compared to continuous infusion 5, 6
• Continue patients' baseline long-acting opioid regimen if already receiving it for chronic pain 5
• Do not presume opioid dependence - true dependence is uncommon in sickle cell disease, whereas heightened opioid sensitivity is more frequently observed 5, 6
• Hydromorphone PCA is recommended for severe pain requiring parenteral opioids 6, 7

Step 4: Hydration Strategy

• Favor oral hydration when feasible, offering clear fluids up to 1-2 hours before any procedural intervention 5
• Reserve intravenous fluid administration for cases where oral intake is insufficient or impossible 5
• Use 5% dextrose solution or 5% dextrose in 25% normal saline (not normal saline alone, as hyposthenuria reduces ability to excrete sodium load) 4
• Monitor fluid balance meticulously, replacing losses accurately and avoiding both dehydration and fluid overload 5, 6

Step 5: Infection Management

• Obtain blood cultures whenever temperature reaches ≥38°C to identify possible bacteremia 5, 7
• Initiate empiric antibiotic therapy promptly for any fever ≥38°C or clinical signs of sepsis, recognizing that individuals with sickle cell disease are functionally asplenic 5, 7
• Continue prophylactic penicillin unless current surgical prophylaxis already provides adequate gram-positive coverage 5, 6
• Inspect intravenous cannula sites at least every shift and remove any line showing redness or swelling to prevent phlebitis 5, 6

Step 6: Oxygen and Temperature Management

• Document baseline oxygen saturation before initiating supplemental oxygen 6
• Reserve supplemental oxygen for clinically indicated hypoxia only - hypoxia promotes hemoglobin polymerization and worsens sickling 6
• Continue oxygen for 24 hours or until patient can mobilize freely, then monitor continuously until room-air saturation returns to baseline 6
• Maintain normothermia using active warming measures such as warmed intravenous fluids and increased ambient temperature 6
• Avoid hypothermia as it induces shivering, peripheral stasis, hypoxia, and increased sickling 6

Step 7: Transfusion Decisions

Routine red-cell transfusion is NOT indicated for uncomplicated vaso-occlusive crises 5

Reserve transfusion for specific complications:

• Acute chest syndrome
• Stroke
• Splenic sequestration with severe anemia and shock 1, 5

When transfusion is required:

• Consult hematology first due to risks including hyperviscosity, alloimmunization (7-30% of transfused patients), and hyperhemolysis 5
• Target hemoglobin concentration of approximately 100 g/L (10 g/dL) to minimize hyperviscosity 5
• Use blood that is ABO-compatible and fully matched for Rh and Kell antigens 5
• For life-threatening complications (severe acute chest syndrome or stroke), consider exchange transfusion under hematology direction 5, 6
• Critical pitfall: Avoid acute overtransfusion to hemoglobin >10 g/dL in splenic sequestration, as sequestered red cells may be acutely released 1

Step 8: Thromboprophylaxis and Mobilization

• Administer routine thromboprophylaxis to all post-pubertal patients to prevent venous thromboembolism 5, 6
• Encourage early mobilization to reduce risk of deep-vein thrombosis and respiratory complications 5, 6
• For patients unable to mobilize, perform chest physiotherapy and incentive spirometry every 2 hours 6
• Provide bronchodilator therapy for patients with history of small-airway obstruction, asthma, or acute chest syndrome 6

Step 9: Multidisciplinary Coordination

• Alert the hematology service at the time of admission for any emergency presentation of sickle cell crisis 5
• Engage the pain-management team early for patients with known opioid tolerance or complex analgesic requirements 5
• Arrange daily evaluation by a hematologist (or pediatrician for children) after moderate or major complications 5, 6, 7
• Maintain high index of suspicion for sickle-cell-related complications, which can mimic other acute medical conditions 5, 7

Step 10: Critical Care Escalation

• Admit patients to intensive care who develop life-threatening complications such as acute chest syndrome, stroke, or sepsis 5, 7
• Consider emergency exchange transfusion when indicated, under direction of the hematology team 5, 6
• Close cardiorespiratory status monitoring is mandatory during opioid therapy 6, 7

Critical Pitfalls to Avoid

• Never assume opioid dependency - opioid dependency is rare in sickle cell disease, while opioid sensitivity is more common 5, 6
• Do not give iron supplementation unless iron deficiency is biochemically proven, as repeated transfusions create iron overload risk 7
• Avoid routine surgery or procedures if patient is febrile or having active painful crisis 7
• Do not use oxygen routinely - reserve for documented hypoxia only 6
• Never delay pain treatment waiting for objective findings - patient self-report is the gold standard 5